Prescription drug · NDA
Argatroban NDC 0143-9674
Argatroban 250 mg/2.5mL · Injection · Intravenous · Hikma Pharmaceuticals USA Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0143-9674-01 | 0014396740100143967401 | 2.5 mL in 1 VIAL (0143-9674-01)Marketed from Jan 5, 2012 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Argatroban
- Generic name (nonproprietary)
- argatroban
- Active ingredients
- Argatroban — 250 mg/2.5mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- Hikma Pharmaceuticals USA Inc.NDC labeler code 0143
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 203049
- Marketing start
- Listing expires
- Other FDA classes
- Thrombin Inhibitors (Mechanism)
- Identifiers
- Product ID 0143-9674_6581f4f1-6a34-4f92-8e37-7587f75c4e71SPL ID 6581f4f1-6a34-4f92-8e37-7587f75c4e71SPL set ID 0cdf3f67-5bf3-4d58-b330-03febdc652bfRxCUI 308351, 1804735UNII IY90U61Z3S
- Pharmacologic class
- Anti-coagulant; Direct Thrombin Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400143967401followed by a unit qualifier and the quantityPackage 00143-9674-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Argatroban is a direct thrombin inhibitor indicated: For prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT) ( 1.1 ) As an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI) ( 1.2 ) 1.1 Heparin-Induced Thrombocytopenia Argatroban Injection is indicated for prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT). 1.2 Percutaneous Coronary Intervention Argatroban Injection is indicated as an anticoagulant in adult patients with or at risk for HIT undergoing percutaneous coronary intervention (PCI).
Excerpt only. Read the full label for complete information.
About NDC 0143-9674
- What is NDC 0143-9674?
- 0143-9674 is the product NDC for Argatroban, Argatroban 250 mg/2.5mL injection, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Argatroban.
- What is the active ingredient?
- Argatroban.
- Who is the labeler?
- Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Argatroban?
- 16 other product NDCs are listed under this name. See all Argatroban NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Argatroban products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Argatroban | Argatroban 50 mg/50mL | InjectionIntravenous | Caplin Steriles Limited | 65145-126 | 65145-0126-01 |
| Argatroban | Argatroban 50 mg/50mL | InjectionIntravenous | Mullan Pharmaceutical Inc. | 83301-0062 | 83301-0062-01 |
| Argatroban | Argatroban 50 mg/50mL | InjectionIntravenous | Mullan Pharmaceutical Inc. | 83301-0500 | 83301-0500-01 |
| Argatroban | Argatroban 50 mg/50mL | Injection, SolutionIntravenous | Gland Pharma Limited | 68083-568 | 68083-0568-01 |
| Argatroban | Argatroban 1 mg/mL | InjectionIntravenous | Accord Healthcare Inc. | 16729-430 | 16729-0430-1116729-0430-43 |
| Argatroban | Argatroban 50 mg/50mL | InjectionIntravenous | Fresenius Kabi USA, LLC | 65219-429 | 65219-0429-50 |
| Argatroban | Argatroban 1 mg/mL | Injection, SolutionIntravenous | Sagent Pharmaceuticals | 25021-414 | 25021-0414-50 |
| Argatroban | Argatroban 50 mg/50mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9377 | 00143-9377-01 |
| Argatroban | Argatroban 50 mg/50mL | Injection, SolutionIntravenous | Eugia US LLC | 55150-241 | 55150-0241-0155150-0241-10 |
| Argatroban | Argatroban 100 mg/mL | Injection, SolutionIntravenous | Amneal Pharmaceuticals LLC | 70121-1037 | 70121-1037-01 |
Other NDCs under NDA 203049
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Argatroban | Argatroban 250 mg/2.5mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9288 |
| Argatroban | Argatroban 50 mg/50mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9377 |
| Argatroban | Argatroban 50 mg/50mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9559 |